Reviews Write New Review
[email protected]
Mimi Yen
Co-founder & CEO of PhagePro
Dr. Yen researched the use of phages as an intervention for cholera during her thesis work in the Camilli Lab at Tufts University, resulting in publications in Nature Communications and eLife. As a biological engineering undergraduate at MIT, she trained with Professors David Schauer and Darrell Irvine and researched oral vaccine delivery. Passionate about developing innovative solutions for infectious diseases, Dr. Yen was awarded the Howard Hughes Medical Institute MERGE-ID fellowship, which focused on translating bench science to clinical applications, for her graduate education. During her thesis research, Dr. Yen traveled to Haiti to study the cholera epidemic, where she witnessed the need for innovative healthcare solutions. With her thesis advisor Professor Andrew Camilli and a postdoctoral researcher Dr. Lynne Cairns, she founded PhagePro with the mission to develop phage therapies to help the world’s most vulnerable communities. To understand the context in which PhagePro would operate, Dr. Yen pursued a Master’s in Public Health at Boston University, with a focus in global health and program management. For her cholera phage prophylaxis work, she has recently been recognized by MIT Technology Review in the 35 Innovators under 35 list for 2018 as a humanitarian. Dr. Yen continues to advocate for the use of phages as a global health intervention and plans to develop them as part of the toolkit to alleviate the burden of diarrheal diseases around the world.
Related Speakers View all
Dr. Hosam Zowawi
Infectious Diseases Scientist, Public Health Strateg...
|
|
Dr. Jason Carlyon
Professor, Department of Microbiology & Immunology a...
|
|
Timothy Nice, PhD
Assistant Professor of Molecular Microbiology and Im...
|
|
Kai W. Wucherpfennig, MD, PhD
Professor, Microbiology and Immunobiology, Harvard M...
|
|
Will McLean
Co-founder & VP of Biology & Regenerative Medicine a...
|
|
Aaron Ring
Associate Professor & Anderson Family Chair for Immu...
|
|
Paul Hastings
Chairman and Chief Executive Officer, OncoMed Pharma...
|
|
Debra Lappin
Principal at Faegre BD Consulting
|
|
Kimber Stanhope
Associate Research Nutritional Biologist at UC Davis...
|
|
Dennis Roop
Director, Center for Regenerative Medicine and Stem ...
|
|
David Hung
Founder, President and CEO of Medivation, 2014 Ernst...
|
|
Francois Nader
President and CEO of NPS Pharmaceuticals
|
|
Christopher Austin
Senior Vice President of Research Technologies at GS...
|
|
Ekemini Riley
Managing Director at Aligning Science Across Parkins...
|
|
Peter Marks
Director at Center for Biologics Evaluation and Rese...
|
|
Shay-Akil McLean
Social & Natural Scientist
|
|
Sally Kornbluth
MIT’s 18th President, Cell Biologist & Former Provos...
|
|
Renee Wegrzyn
Applied Biologist; Director of the Advanced Research...
|
|
Jeffrey Bland
Founder & President of Big Bold Health
|
|
Rebecca Heiss, PhD
Science-Backed Leadership & Performance Speaker; Str...
|